Chemours Company (The) Common Stock (CC)

NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purchased or otherwise acquired the Company’s securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“The Chemours” or the “Company”) (NASDAQ: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.

The DJS Law Group reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products for markets including, refrigeration and air conditioning.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company’s possible violations of the federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company’s possible violations of federal securities laws.

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing.

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company.

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quarter 2025.

The Chemours Company (“Chemours”) (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025.

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025.

NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSE: CC).

The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the release of its 2024 Sustainability Report, showcasing significant progress toward its Corporate Responsibility Commitment (CRC) goals. The report titled “Trusted Chemistry” is an affirmation of the company’s vision and commitment to using the power of chemistry to solve some of the world’s most pressing challenges while improving lives and helping communities thrive.

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the signing of strategic agreements with SRF Limited (SRF), a diversified, chemical-based multi-business conglomerate headquartered in India. SRF is engaged in the manufacturing of industrial and specialty intermediates, including fluoropolymers.